The 2019 medical conference brings important information on RA drug therapies, better understanding of diseases causes and symptom management, and more ways to help patients feel better.
Continue reading
The 2019 medical conference brings important information on new drug therapies, better understanding of diseases causes and symptom management, and more ways to help patients feel better.
Continue reading
Anifrolumab will seek FDA approval.
Continue reading
This may be a good option for patients who shouldn’t use NSAIDs or colchicine to treat gout flares.
Continue reading
When temperatures drop, joint pain can act up. Use these tips from rheumatologists and fellow patients to keep yourself cozy and pain-free in cold weather.
Continue reading
“Giant cell arteritis requires ongoing management, but it does not necessarily require continuous treatment.”
Continue reading
Researchers are very interested in seeing which factors might be used to predict — and help prevent — rheumatoid arthritis in at-risk people.
Continue reading
This is eye-opening and important for lupus patients to know: African Americans with lupus were 18 times more likely than Caucasian patients to suffer a cardiovascular event during a 10-year period.
Continue reading
With advancements in rheumatoid arthritis medication, those with osteoarthritis may now have a higher disease burden overall.
Continue reading
Vagus nerve stimulation and splenic nerve stimulation are being studied for their potential to help RA patients who don’t respond to medication such as biologics. Here’s what you need to know.
Continue reading
